Amy J Mathers, MD, D(ABMM)
Disclosures: Consulting Fee-Antimicrobial Resistance (AMR) Services|Consulting Fee-Accelerate Diganostics|Consulting Fee-VenatoRx|Contracted Research-zavante therapeutics

Dr. Amy Mathers MD, D(ABMM) is an Associate Professor of Medicine and Pathology at the University of Virginia.  She is Clinical Director of the Adult Antimicrobial Stewardship Program and is Associate Director of Clinical Microbiology for the University of Virginia Medical Center.

 

Focusing on the urgent clinical problem of increasing carbapenem resistance in Enterobacteriaceae she has been evaluating detection methods in clinical microbiology and molecular transmission of carbapenemase genes for the last ten years with a focus on the hospital environment. Molecular characterization has included analysis of mobile resistance mechanisms with evaluation of plasmid evolution and mobility across species with next generation sequencing paired with more traditional techniques.  With current support for the Centers for Disease Control and Prevention she has been recently investigating the role that the hospital environment can play in evolution and dissemination of carbapenemase genes. 

 

With additional interest in antimicrobial susceptibility testing and its relation to antimicrobial use and stewardship, she is a current voting member of the Clinical Laboratory and Standards Institute (CLSI) Antimicrobial Susceptibility Testing Committee. She is the IDSA liaison for the CLSI.

 

More about the Speaker!

  1. What led you to a career in infectious diseases? I love studying bacteria and their ability to exchange and alter DNA

 

  1. Who is your Infectious Diseases hero? Esther Lederberg

 

  1. What is your proudest achievement? Or what is the most rewarding aspect of a career in ID? I love discovery

 

  1. What do you think is the biggest challenge in ID today? Antimicrobial resistance

 

  1. While ID is a big part of your life, we know that you have other passions! How do you relax in your spare time? Cooking